Valuation: Sanofi

Market Cap 8.82TCr 9.9TCr 8.17TCr 7.4TCr 14TCr 9,38200Cr 14TCr 98TCr 39TCr 4,91000Cr 37TCr 36TCr 15,66300Cr P/E 2026 *
11.7x
P/E 2027 * 10.1x
Enterprise Value 9.95TCr 11TCr 9.22TCr 8.36TCr 16TCr 10,58900Cr 16TCr 1,10600Cr 43TCr 5,54100Cr 42TCr 41TCr 17,67700Cr EV / Sales 2026 *
2.09x
EV / Sales 2027 * 1.9x
Free-Float
88.34%
Yield 2026 *
5.8%
Yield 2027 * 6.13%
1 day+3.62%
1 week+2.77%
Current month+1.29%
1 month-0.63%
3 months-4.86%
6 months-10.29%
Current year-11.05%
1 week 70.1
Extreme 70.1
73.58
1 month 69.75
Extreme 69.75
75.3
Current year 69.75
Extreme 69.75
84.97
1 year 69.75
Extreme 69.75
91.15
3 years 69.75
Extreme 69.75
110.88
5 years 69.75
Extreme 69.75
110.88
10 years 62.88
Extreme 62.88
110.88
Manager TitleAgeSince
Chief Executive Officer 65 01/05/2026
Director of Finance/CFO 64 01/04/2024
Chief Tech/Sci/R&D Officer - 01/09/2026
Director TitleAgeSince
Director/Board Member 61 30/04/2019
Director/Board Member 56 28/04/2020
Director/Board Member 65 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
20/08/26 Buy

Chief Executive Officer

1,506 0.0001%
20/08/26 Buy

Head of Human Resources

54 0.0000%
20/08/26 Buy

Executive/Senior Manager

840 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.62%+2.77%-14.87%-25.53% 9.54TCr
+3.49%+8.54%+59.89%+117.27% 1,10600Cr
+2.19%-1.66%+34.23%+70.27% 61TCr
+2.26%+2.83%+25.92%+98.65% 50TCr
+2.58%+8.31%+37.43%+63.51% 37TCr
+3.25%+1.96%+74.90%+47.67% 35TCr
+1.85%+5.45%+21.38%+49.26% 29TCr
+1.76%+4.92%+0.48%+20.31% 26TCr
+3.29%+5.12%+46.90%+56.43% 23TCr
+2.25%+4.04%+27.44%+99.53% 19TCr
Average +2.69%+1.83%+31.37%+59.74% 39.96TCr
Weighted average by Cap. +2.91%+2.23%+40.34%+77.80%

Financials

2026 *2027 *
Net sales 4.76TCr 5.34TCr 4.41TCr 3.99TCr 7.51TCr 5,06200Cr 7.63TCr 53TCr 21TCr 2,64900Cr 20TCr 20TCr 8,45100Cr 5.07TCr 5.69TCr 4.7TCr 4.26TCr 8TCr 5,39300Cr 8.13TCr 56TCr 22TCr 2,82200Cr 21TCr 21TCr 9,00400Cr
Net income 767.03Cr 861.74Cr 710.88Cr 644.18Cr 1.21TCr 82TCr 1.23TCr 8.53TCr 3.35TCr 43TCr 3.23TCr 3.17TCr 1,36300Cr 907.32Cr 1.02TCr 840.9Cr 761.99Cr 1.43TCr 97TCr 1.46TCr 10TCr 3.96TCr 51TCr 3.82TCr 3.74TCr 1,61200Cr
Net Debt 1.13TCr 1.27TCr 1.05TCr 952.14Cr 1.79TCr 1,20700Cr 1.82TCr 13TCr 4.95TCr 63TCr 4.78TCr 4.68TCr 2,01400Cr 800.45Cr 899.28Cr 741.85Cr 672.24Cr 1.26TCr 85TCr 1.28TCr 8.9TCr 3.5TCr 45TCr 3.37TCr 3.3TCr 1,42200Cr
Projected Income Statement - Annual - Sanofi
Logo Sanofi
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (81.8%): prescription drugs for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases; - human vaccines (18.2%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas. At the end of 2025, the group had 37 production sites worldwide. Net sales are distributed geographically as follows: France (3.9%), Europe (17.1%), the United States (50.8%), China (6%) and other (22.2%).
Employees
74,846
Date Price Change Volume
20/26/20 €73.58 +3.62% 19,26,589
19/26/19 €71.01 -1.29% 18,69,514
16/26/16 €71.94 -0.30% 21,88,087
15/26/15 €72.16 +0.47% 30,60,750
14/26/14 €71.82 +1.53% 32,22,320
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Sanofi
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
71.01EUR
Average target price
93.35EUR
Spread / Average Target
+31.46%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sanofi